A randomised double‐blind study comparing the effect of 1072‐nm light against placebo for the treatment of herpes labialis

@article{Hargate2006ARD,
  title={A randomised double‐blind study comparing the effect of 1072‐nm light against placebo for the treatment of herpes labialis},
  author={George Hargate},
  journal={Clinical and Experimental Dermatology},
  year={2006},
  volume={31}
}
  • G. Hargate
  • Published 1 September 2006
  • Medicine
  • Clinical and Experimental Dermatology
Background.  Previous research demonstrated that 1072‐nm narrowband laser light is effective in the treatment of cold sores. 

Evaluation of the efficacy of low‐level light therapy using 1072 nm infrared light for the treatment of herpes simplex labialis

Low‐level light therapy (LLLT) using 1072 nm infrared light is effective in reducing the duration of herpes simplex labialis episodes and enhancing the healing process.

Light‐emitting diodes in dermatology: A systematic review of randomized controlled trials

The goal of this systematic review is to critically analyze published randomized controlled trials and provide evidence‐based recommendations on the therapeutic uses of LEDs in dermatology based on published efficacy and safety data.

Comparing the effect of diode laser against acyclovir cream for the treatment of herpes labialis

Treatment with diode laser reduced the length of recovery time and pain severity faster than treatment with acyclovir cream and low level laser therapy.

Is low-level laser therapy effective in the treatment of herpes labialis? Systematic review and meta-analysis

The use of low-level laser proved to be effective in the treatment of herpes labialis, but due to the high risk of bias in the included studies, there is a need to carry out new standardized studies to prove the effectiveness of this therapy.

Efficacy of low-level laser therapy in management of recurrent herpes labialis: a systematic review

It is suggested that laser is potentially a safe and effective treatment alternative for the management of RHL, however, due to high variability in study designs and inconsistency in laser parameters among the included studies, more well-designed randomized clinical trials with standardized laser parameters are highly warranted.

Does low-level light therapy accelerate healing time of oral herpes simplex lesions?

Direct application of low-level light therapy significantly accelerates the healing time of oral herpes simplex lesions and exhibited great patient satisfaction, as they did not have to endure unsightly facial lesions for a long duration of time, and their symptoms of pain and burning were significantly reduced.

Phototherapy in the treatment of cutaneous herpesvirus manifestations.

Evidence from the reviewed literature indicates that short-term efficacy from treatment with phototherapy is the most likely outcome, however, long-term effects and follow-up of this treatment modality are lacking but appear promising.

Therapeutic Efficacy of Home-Use Photobiomodulation Devices: A Systematic Literature Review.

Home-use PBM devices appear to mediate effective, safe treatments in a variety of conditions that require frequent applications, but conclusive evaluation of their efficacy requires additional, randomized controlled studies.

Therapeutic Efficacy of Home-Use Photobiomodulation Devices: A Systematic Literature Review.

Home-use PBM devices appear to mediate effective, safe treatments in a variety of conditions that require frequent applications, but conclusive evaluation of their efficacy requires additional, randomized controlled studies.

Enhancement of cutaneous immune response to bacterial infection after low-level light therapy with 1072 nm infrared light: a preliminary study.

A pilot study of treatment of herpes labialis with 1072 nm narrow waveband light

It is demonstrated that a single 5 min light treatment significantly reduced cold sore healing time by 4“days; 1072 nm light healed cold sores in 4.3 ± 1.8 days (mean ± SD) as compared with aciclovir applied five times daily, 8.5‰±‰3.0‰days (P < 0.0001).

Acyclovir Cream for Treatment of Herpes Simplex Labialis: Results of Two Randomized, Double-Blind, Vehicle-Controlled, Multicenter Clinical Trials

Acyclovir cream did not prevent the development of classical lesions (progression to vesicles, ulcers, and/or crusts) and there was a statistically significant reduction in the duration of lesion pain in both studies.

Pathogenesis of herpes simplex labialis: experimental induction of lesions with UV light

  • S. Spruance
  • Medicine
    Journal of clinical microbiology
  • 1985
To develop a model system of herpes simplex labialis which would enable the study of patients before lesion onset, five patients were exposed to various doses of UV light from a sunlamp at their

The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir.

ACV therapy can be efficacious, but some rapidly developing lesions are unresponsive to treatment, which suggests that more than one process may contribute to the pathogenesis of herpes labialis.

Improvement of host response to sepsis by photobiomodulation

Whether laser irradiation has a stimulatory effect on the immune response in sepsis using an animal model is determined and ATP‐MgCL2 appears to improve cellular energetics and decrease mortality.

Cross-sectional study of recurrent herpes labialis. Prevalence and risk factors.

Consecutive blood donors at 25 sites in southern Wisconsin were interviewed in 1985 to ascertain recurrent herpes labialis histories, other perioral conditions, and status on possible predisposing

Treatment modalities and medication recommended by health care professionals for treating recurrent herpes labialis.

Variation in treatment modalities and recommendations by each health profession is found, despite the fact that patients reported similar triggers and concerns, according to individual patient need and health care professional's lack of knowledge.

Laser modulation of human immune system: Inhibition of lymphocyte proliferation by a gallium‐arsenide laser at low energy

The results indicate that laser irradiation at low energy can interfere with immune system in vitro, and similar modulation could potentially occur in human subjects exposed to laser irradiated in vivo.